Treatment of colon cancer cells with EGCG restored RXRα protein levels and reduced the amount of promoter methylation, revealing more evidence for EGCG as an epigenetic regulator in colon cancer chemoprevention. Here, RXRA is linked to malignant colon neoplasm.